National Institute Of Tuberculosis And Lung Diseases

Research site

Poland Ul. Curie-Sklodowskiej 2, 34-700 Rabka Zdrój, Poland

Cystic fibrosis respiratory infection suppression · Cystic fibrosis lung
Adult patients

About Specializations

National Institute Of Tuberculosis And Lung Diseases in Rabka Zdrój, Poland specialises in clinical trials of conditions such as Cystic fibrosis respiratory infection suppression, Cystic fibrosis lung, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Ul. Curie-Sklodowskiej 234-700 Rabka ZdrójPoland

Open in maps ↗

Recruiting now: no trials
Conditions studied: 2

More sites in Rabka Zdrój Poland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

2 clinical trials

Cystic fibrosis respiratory infection suppression

Not recruiting

Study of inhaled BX004 bacteriophage treatment for adults with cystic fibrosis who have chronic Pseudomonas aeruginosa lung infection

Investigational

Study of inhaled BX004 bacteriophage treatment for adults with cystic fibrosis who have chronic Pseudomonas aeruginosa lung infection

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:IHMA-2121771-1
Sponsor:Biomx Ltd.

Contact Research Centre

Cystic fibrosis lung

Not recruiting

Safety and effectiveness study of inhaled ARCT-032 (mRNA therapy) in adults with Cystic Fibrosis

InvestigationalNo placebo

Safety and effectiveness study of inhaled ARCT-032 (mRNA therapy) in adults with Cystic Fibrosis

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Sponsor:Arcturus Therapeutics Europe B.V.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites